MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
2.790
+0.160 (6.08%)
At close: Apr 28, 2026, 4:00 PM EDT
2.830
+0.040 (1.43%)
After-hours: Apr 28, 2026, 7:58 PM EDT
MannKind Market Cap
MannKind has a market cap or net worth of $861.54 million as of April 28, 2026. Its market cap has decreased by -38.84% in one year.
Market Cap
861.54M
Enterprise Value
1.17B
1-Year Change
-38.84%
Ranking
Category
Stock Price
$2.79
Market Cap Chart
Since July 28, 2004, MannKind's market cap has increased from $445.50M to $861.54M, an increase of 93.39%. That is a compound annual growth rate of 3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 810.30M | -53.46% |
| Dec 31, 2025 | 1.74B | -1.82% |
| Dec 31, 2024 | 1.77B | 80.71% |
| Dec 29, 2023 | 981.30M | -29.25% |
| Dec 30, 2022 | 1.39B | 26.32% |
| Dec 31, 2021 | 1.10B | 50.82% |
| Dec 31, 2020 | 728.00M | 173.38% |
| Dec 31, 2019 | 266.30M | 57.39% |
| Dec 31, 2018 | 169.20M | -37.75% |
| Dec 29, 2017 | 271.80M | -10.74% |
| Dec 30, 2016 | 304.50M | -48.72% |
| Dec 31, 2015 | 593.80M | -71.93% |
| Dec 31, 2014 | 2.12B | 13.87% |
| Dec 31, 2013 | 1.86B | 227.29% |
| Dec 31, 2012 | 567.70M | 72.92% |
| Dec 30, 2011 | 328.30M | -67.35% |
| Dec 31, 2010 | 1.01B | 1.76% |
| Dec 31, 2009 | 988.20M | 183.23% |
| Dec 31, 2008 | 348.90M | -56.57% |
| Dec 31, 2007 | 803.30M | -2.49% |
| Dec 29, 2006 | 823.80M | 45.65% |
| Dec 30, 2005 | 565.60M | 9.46% |
| Dec 31, 2004 | 516.70M | 15.98% |
| Jul 28, 2004 | 445.50M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 874.86M |
| Bright Minds Biosciences | 873.45M |
| SELLAS Life Sciences Group | 863.79M |
| MeiraGTx Holdings | 859.86M |
| Alto Neuroscience | 855.11M |
| Arbutus Biopharma | 854.72M |
| Crescent Biopharma | 825.41M |
| Cullinan Therapeutics | 821.34M |